Cargando…

Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA

BACKGROUND: The gut-cardiac axis theory provides new insights into the complex mechanisms of cardiac hypertrophy and provides new therapeutic targets. Cardiac hypertrophy is a risk factor for heart failure. Shengmaiyin (SMY) is a traditional Chinese medicine formula with clear effects in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Sitong, Kan, Mo, Liu, Liu, Zhang, Zhuang, Liu, Xiaoran, Liu, Yaxin, Li, Zhen, Zhang, Yanhong, Pang, Qihang, Lin, Jianan, Li, Hui, Yang, Qing, Sui, Xin, Qu, Xiaobo, Li, Na
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473885/
https://www.ncbi.nlm.nih.gov/pubmed/36118100
http://dx.doi.org/10.1155/2022/3188292
_version_ 1784789595378941952
author Ming, Sitong
Kan, Mo
Liu, Liu
Zhang, Zhuang
Liu, Xiaoran
Liu, Yaxin
Li, Zhen
Zhang, Yanhong
Pang, Qihang
Lin, Jianan
Li, Hui
Yang, Qing
Sui, Xin
Qu, Xiaobo
Li, Na
author_facet Ming, Sitong
Kan, Mo
Liu, Liu
Zhang, Zhuang
Liu, Xiaoran
Liu, Yaxin
Li, Zhen
Zhang, Yanhong
Pang, Qihang
Lin, Jianan
Li, Hui
Yang, Qing
Sui, Xin
Qu, Xiaobo
Li, Na
author_sort Ming, Sitong
collection PubMed
description BACKGROUND: The gut-cardiac axis theory provides new insights into the complex mechanisms of cardiac hypertrophy and provides new therapeutic targets. Cardiac hypertrophy is a risk factor for heart failure. Shengmaiyin (SMY) is a traditional Chinese medicine formula with clear effects in the treatment and prevention of cardiac hypertrophy, but the mechanism by which it improves cardiac hypertrophy is still unclear. Therefore, this study aimed to investigate the protective effect and mechanism of SMY on isoproterenol (ISO)-induced myocardial hypertrophy in rats. METHODS: First, various pharmacodynamic methods were used to evaluate the therapeutic effect of SMY on ISO-induced myocardial hypertrophy in rats. Then, 16S rDNA amplicon sequencing technology was used to study the effect of SMY on the intestinal flora of rats with myocardial hypertrophy. Finally, the mechanism underlying the effect of SMY on cardiac hypertrophy was predicted by bioinformatics network analysis and verified by Western blotting. RESULTS: SMY increased ejection fraction (EF%) and left ventricular fractional shortening (FS%), ameliorated myocardial cell injury and fibrosis, regulated blood lipids and energy metabolism, and decreased cardiac hypertrophy marker gene expression. The gut microbiota of ISO-induced myocardial hypertrophy rats were significantly changed, while SMY effectively ameliorated the dysbiosis of the intestinal flora in rats with myocardial hypertrophy, especially Prevotella 9, Lactobacillus, and Clostridium. Mechanistic studies have shown that the anticardiac hypertrophy effect of SMY is related to the inhibition of the expression of HIF1α/PPAR signalling pathway-related proteins. CONCLUSION: SMY significantly improves cardiac function, relieves myocardial cell fibrosis and necrosis, resists cardiac hypertrophy, improves blood lipid metabolism and energy metabolism, regulates intestinal microbial disturbance, and protects the heart.
format Online
Article
Text
id pubmed-9473885
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-94738852022-09-15 Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA Ming, Sitong Kan, Mo Liu, Liu Zhang, Zhuang Liu, Xiaoran Liu, Yaxin Li, Zhen Zhang, Yanhong Pang, Qihang Lin, Jianan Li, Hui Yang, Qing Sui, Xin Qu, Xiaobo Li, Na Evid Based Complement Alternat Med Research Article BACKGROUND: The gut-cardiac axis theory provides new insights into the complex mechanisms of cardiac hypertrophy and provides new therapeutic targets. Cardiac hypertrophy is a risk factor for heart failure. Shengmaiyin (SMY) is a traditional Chinese medicine formula with clear effects in the treatment and prevention of cardiac hypertrophy, but the mechanism by which it improves cardiac hypertrophy is still unclear. Therefore, this study aimed to investigate the protective effect and mechanism of SMY on isoproterenol (ISO)-induced myocardial hypertrophy in rats. METHODS: First, various pharmacodynamic methods were used to evaluate the therapeutic effect of SMY on ISO-induced myocardial hypertrophy in rats. Then, 16S rDNA amplicon sequencing technology was used to study the effect of SMY on the intestinal flora of rats with myocardial hypertrophy. Finally, the mechanism underlying the effect of SMY on cardiac hypertrophy was predicted by bioinformatics network analysis and verified by Western blotting. RESULTS: SMY increased ejection fraction (EF%) and left ventricular fractional shortening (FS%), ameliorated myocardial cell injury and fibrosis, regulated blood lipids and energy metabolism, and decreased cardiac hypertrophy marker gene expression. The gut microbiota of ISO-induced myocardial hypertrophy rats were significantly changed, while SMY effectively ameliorated the dysbiosis of the intestinal flora in rats with myocardial hypertrophy, especially Prevotella 9, Lactobacillus, and Clostridium. Mechanistic studies have shown that the anticardiac hypertrophy effect of SMY is related to the inhibition of the expression of HIF1α/PPAR signalling pathway-related proteins. CONCLUSION: SMY significantly improves cardiac function, relieves myocardial cell fibrosis and necrosis, resists cardiac hypertrophy, improves blood lipid metabolism and energy metabolism, regulates intestinal microbial disturbance, and protects the heart. Hindawi 2022-09-07 /pmc/articles/PMC9473885/ /pubmed/36118100 http://dx.doi.org/10.1155/2022/3188292 Text en Copyright © 2022 Sitong Ming et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ming, Sitong
Kan, Mo
Liu, Liu
Zhang, Zhuang
Liu, Xiaoran
Liu, Yaxin
Li, Zhen
Zhang, Yanhong
Pang, Qihang
Lin, Jianan
Li, Hui
Yang, Qing
Sui, Xin
Qu, Xiaobo
Li, Na
Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
title Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
title_full Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
title_fullStr Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
title_full_unstemmed Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
title_short Protective Effect of Shengmaiyin in Myocardial Hypertrophy-Induced Rats: A Genomic Analysis by 16S rDNA
title_sort protective effect of shengmaiyin in myocardial hypertrophy-induced rats: a genomic analysis by 16s rdna
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473885/
https://www.ncbi.nlm.nih.gov/pubmed/36118100
http://dx.doi.org/10.1155/2022/3188292
work_keys_str_mv AT mingsitong protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT kanmo protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT liuliu protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT zhangzhuang protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT liuxiaoran protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT liuyaxin protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT lizhen protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT zhangyanhong protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT pangqihang protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT linjianan protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT lihui protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT yangqing protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT suixin protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT quxiaobo protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna
AT lina protectiveeffectofshengmaiyininmyocardialhypertrophyinducedratsagenomicanalysisby16srdna